Pain is a common and often debilitating symptom for individuals with Parkinson's disease (PD), impacting their quality of life. While previous research has suggested that pain affects approximately 25% of PD patients in Korea, there is a lack of understanding about the effectiveness of treatments, both pharmacological and non-pharmacological, for managing this symptom.
Enter physical exercise, a non-pharmacological approach that has shown promise in modulating pain through its effects on central pain processing, enhancing inhibitory control, and altering neurotransmitter signaling. But here's where it gets controversial: pain subtypes, arising from different pathophysiological mechanisms, may respond differently to exercise.
This study aims to explore the impact of cycling exercise, a widely accessible and effective aerobic exercise for PD, on various pain types. We hypothesized that pain subtypes would exhibit distinct responses to this form of exercise.
The study design was a randomized controlled pilot trial, with participants randomly allocated to high-intensity interval cycling, moderate-intensity continuous cycling, or a usual care group. The cycling groups received supervised aerobic exercise interventions using a cycle ergometer for 24 weeks.
To assess pain, the King's Parkinson's Disease Pain Scale (KPPS) was used, a reliable and valid self-reported questionnaire. The scale covers various pain domains, including musculoskeletal pain, chronic body pain, fluctuation-related pain, nocturnal pain, orofacial pain, discoloration/edema and swelling, and radicular pain.
Results showed that cycling exercise may be effective in alleviating fluctuation-related pain, nocturnal pain, and orofacial pain in patients with early PD. Interestingly, these improvements could be mediated by dopaminergic pathways, as these pain types are closely linked to motor fluctuations and conditions like restless legs syndrome (RLS) and periodic leg movements (PLM), which respond well to dopaminergic medications.
However, the study also revealed a notable downside: 40% of cycling participants developed new musculoskeletal pain, compared to only 20% in the control group. This finding underscores the importance of recognizing potential risks associated with cycling, especially for PD patients who are susceptible to age- or disease-related musculoskeletal strain.
Despite these positive and negative findings, the study had limitations, including small subgroup sizes, which restricted robust statistical comparisons. The impact of exercise intensity and mode on pain outcomes could not be investigated due to the combined analysis of high-intensity and moderate-intensity training groups.
In conclusion, this exploratory analysis suggests that cycling exercise may benefit certain pain types in early PD, but these potential benefits must be carefully weighed against the risk of developing new musculoskeletal pain. Further large-scale trials are needed to confirm these findings and explore the potential synergistic effects of combining physical exercise with non-invasive neuromodulation techniques.
